Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
absence, AesRx, aggregate, agreed, Aibonito, anniversary, assert, assistance, ASU, attached, bound, Butel, categorized, cell, COBRA, coverage, dosing, eligible, employment, ensure, entirety, exceeding, Exhibit, feasibility, field, FVIII, herewith, Hombach, II, incremental, individually, largely, Library, lump, obsolescence, outplacement, particulate, party, pay, Pennsylvania, permitted, preclinical, predominantly, President, pulmonary, qualified, rata, recovery, residual, retrospectively, revised, Robert, role, salary, sell, sickle, stage, sum, target, text, Topic, twelve, ultimate, Vice, waive
Filing tables
Filing exhibits
BAX similar filings
Filing view
External links
EXHIBIT 15
July 30, 2014
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Commissioners:
We are aware that our report dated July 30, 2014 on our review of interim financial information of Baxter International Inc. (the “company”) for the three- and six-month periods ended June 30, 2014 and 2013 and included in the company’s quarterly report on Form 10-Q for the quarter ended June 30, 2014 is incorporated by reference in its Registration Statements on Form S-8 (Nos. 333-43563, 333-47019, 333-88257, 333-48906, 333-62820, 333-102140, 333-104420, 333-104421, 333-105032, 333-143063, 333-174400 and 333-174401) and on Form S-3 (Nos. 333-123811 and 333-183099).
Very truly yours,
/s/ PricewaterhouseCoopers LLP
Chicago, Illinois